SCHEMBL3690407

SCHEMBL3690407

C[C@@H](C(=O)C(F)C(=O)C(F)C(=O)[C@H](C)N(C(=O)OCc1ccccc1)c1ccccc1)N(C(=O)OCc1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
ABCB1 P08183 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CCR6 P51684 1/20 0.37
PAX8 Q06710 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3690405 0.86 ALDH1A1 (0.40) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL1812242 0.85 ALDH1A1 (0.49) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL5229233 0.85 ALDH1A1 (0.49) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL10515353 0.85 ALDH1A1 (0.49) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL11059329 0.80 ALDH1A1 (0.47) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL7448004 0.79 PPARG (0.44) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL7448000 0.79 PPARG (0.44) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL7627852 0.77 LMNA (0.47) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL10556602 0.77 ALDH1A1 (0.46) ALDH1A1SLC6A2SLC6A3KMT2ATDP1
SCHEMBL7564622 0.77 ALDH1A1 (0.46) ALDH1A1SLC6A2SLC6A3KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838645-B2 comprising antibodies that specifically bind caspase-8 as inhibitors; cancer; activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy UNIVERSITY OF MARYLAND COLLEGE PARK (US) 2010-11-23 US disclosed
US-20050276809-A1 comprising antibodies that specifically bind caspase-8 as inhibitors; cancer; activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-12-15 US disclosed